Literature DB >> 4061276

The persistent defect on exercise thallium imaging and its fate after myocardial revascularization: does it represent scar or ischemia?

P Liu, M C Kiess, R D Okada, P C Block, H W Strauss, G M Pohost, C A Boucher.   

Abstract

Persistent defects on serial thallium scans are commonly thought to represent fibrosis or scar. However, such a pattern may also represent severe ischemia. To better understand persistent defects, exercise thallium and resting gated blood pool scans were reviewed in 52 patients pre and post coronary angioplasty for single-vessel left anterior descending (LAD) coronary artery disease, and the fate of persistent defects after successful revascularization was determined. Persistent and transient defects were defined from the average scores of three observers. Ten patients with 16 myocardial segments with persistent defects were compared to another 11 patients with 20 myocardial segments with transient defects. After angioplasty (PTCA), 75% of the regions that had persistent defects and 85% of the regions that had transient defects were normal by visual assessment. In the persistent defect group, only regional wall motion on the resting gated blood pool scan pre PTCA helped to distinguish those segments that would or would not revert to normal. We conclude that regions of persistent defect on thallium scan often revert to normal after PTCA (75%), suggesting that persistent defects may represent hypoperfusion of viable myocardium, and should not preclude consideration of an intervention.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4061276     DOI: 10.1016/0002-8703(85)90199-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  34 in total

1.  Use of myocardial perfusion imaging to assess viability.

Authors:  M I Travin
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

2.  The clinical impact of thallium-201 reinjection scintigraphy for detection of myocardial viability.

Authors:  A F Kuijper; H W Vliegen; E E van der Wall; W P Oosterhuis; A H Zwinderman; B L van Eck-Smit; M G Niemeyer; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1992

3.  Viable myocardium and reinjection of thallium.

Authors:  S R Underwood; D J Pennell
Journal:  Br Heart J       Date:  1992-12

4.  Preoperative evaluation of myocardial viability by thallium-201 imaging in patients with old myocardial infarction who underwent coronary revascularization.

Authors:  H Naruse; M Ohyanagi; T Iwasaki; T Miyamoto; M Fukuchi
Journal:  Ann Nucl Med       Date:  1992-02       Impact factor: 2.668

Review 5.  Hibernation and myocardial ischemia: clinical detection by positron emission tomography.

Authors:  N G Uren; P G Camici
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

6.  Usefulness of reinjection image for evaluating viable myocardium in the infarcted zone on exercise thallium-201 SPECT.

Authors:  S Tomiguchi; M Takahashi; O Shimomura; A Kojima; M Hara; Y Koga; K Minoda; H Yasue; K Hayasaki
Journal:  Ann Nucl Med       Date:  1991-11       Impact factor: 2.668

7.  A challenge to the nuclear cardiology laboratory: imaging goals in patients after infarction.

Authors:  T P Rocco; M A Pfeffer
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

8.  Comparative accuracy of various Tl-201 reinjection imaging protocols to detect myocardial viability.

Authors:  H Naruse; T Kondo; T Arii; M Morita; M Ohyanagi; T Iwasaki; M Fukuchi
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

9.  Resting technetium-99m methoxyisobutylisonitrile cardiac imaging in chronic coronary artery disease: comparison with rest-redistribution thallium-201 scintigraphy.

Authors:  A Cuocolo; S Maurea; L Pace; E Nicolai; A Nappi; M Imbriaco; B Trimarco; M Salvatore
Journal:  Eur J Nucl Med       Date:  1993-12

10.  Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism.

Authors:  M Kawamoto; N Tamaki; Y Yonekura; E Tadamura; Y Fujibayashi; Y Magata; R Nohara; S Sasayama; K Ikekubo; H Kato
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.